The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function
Open accessAbstract
Angiotensin-converting enzyme 2 (ACE2) is the first human homologue of ACE to be described. ACE2 is a type I integral membrane protein that functions as a carboxypeptidase, cleaving a single hydrophobic/basic residue from the COOH-terminus of its substrates. Because ACE2 efficiently hydrolyzes the potent vasoconstrictor angiotensin II to angiotensin (1–7), this has changed our overall perspective about the classical view of the renin angiotensin system in the regulation of hypertension and heart and renal function, because it represents the first example of a feedforward mechanism directed toward mitigation of the actions of angiotensin II. This paper reviews the new data regarding the biochemistry of angiotensin-(1–7)-forming enzymes and discusses key findings such as the elucidation of the regulatory mechanisms participating in the expression of ACE2 and angiotensin-(1–7) in the control of the circulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 3×
“By applying the emerging concepts of systems biology enunciated by Barabasi and Oltvai (6), it can be readily interpreted that the RAS functions as a hierarchically organized Address for reprint requests and other correspondence: C. M. Ferrario, Hypertension and Vascular Disease Center, Wake Forest Univ. School of Med…”
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733 · cited 3×
“(24) showed that the rat ace2 maps to a quantitative trait locus with a significant logarithm-of-the-odds score for hypertension in three models of hypertension: the Sabra salt-sensitive rat, the spontaneously hypertensive rat (SHR), and the stroke-prone SHR (SHRSP).”
Self-citationFerrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Self-citationHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852
Towler, P., Staker, B., Prasad, S. G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311191200 · Cited by 696
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Self-citationCounterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Self-citationMyocardial infarction increases ACE2 expression in rat and humans
Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi114 · Cited by 423
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor
Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000160867.23556.7d · Cited by 415
The angiotensin–converting enzyme gene family: genomics and pharmacology
Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 406
The mas oncogene encodes an angiotensin receptor
Jackson, T. R., Blair, L. A. C., Marshall, J., Goedert, M., & Hanley, M. R. (1988) · Nature · doi:10.1038/335437a0 · Cited by 395
Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice
Kirchhoff, S., Nelles, E., Hagendorff, A., Krüger, O., Traub, O., & Willecke, K. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70114-9 · Cited by 391
Bumpus, F. M., Catt, K. J., Chiu, A. T., DeGasparo, M., Goodfriend, T., Husain, A., Peach, M. J., Taylor, D. G., & Timmermans, P. B. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.720 · Cited by 385
Santos, R. A. S., Campagnole-Santos, M. J., & Andrade, S. P. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00138-5 · Cited by 380
ACE2, a new regulator of the renin–angiotensin system
Burrell, L. M., Johnston, C. I., Tikellis, C., & Cooper, M. E. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.03.001 · Cited by 362
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000060689.38912.cb · Cited by 350
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Loot, A. E., Roks, A. J. M., Henning, R. H., Tio, R. A., Suurmeijer, A. J. H., Boomsma, F., & van Gilst, W. H. (2002) · Circulation · doi:10.1161/01.cir.0000013847.07035.b9 · Cited by 321
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Self-citationSlow ventricular conduction in mice heterozygous for a connexin43 null mutation.
Guerrero, P. A., Schuessler, R. B., Davis, L. M., Beyer, E. C., Johnson, C. M., Yamada, K. A., & Saffitz, J. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119367 · Cited by 314
Zisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308
Krieger, E. M., Brum, P. C., & Negrão, C. E. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.720 · Cited by 306
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Freeman, E. J., Chisolm, G. M., Ferrario, C. M., & Tallant, E. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.104 · Cited by 295
Self-citationMetabolism of Angiotensin-(1–7) by Angiotensin-Converting Enzyme
Chappell, M. C., Pirro, N. T., Sykes, A., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.362 · Cited by 289
Self-citationSchiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Self-citationFerrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Self-citationWelches, W. R., Bridget Brosnihan, K., & Ferrario, C. M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90108-f · Cited by 254
Self-citationLi, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.394 · Cited by 246
Self-citationDeddish, P. A., Marcic, B., Jackman, H. L., Wang, H.-Z., Skidgel, R. A., & Erdös, E. G. (1998) · Hypertension · doi:10.1161/01.hyp.31.4.912 · Cited by 244
Angiotensin-(1-7): Cardioprotective Effect in Myocardial Ischemia/Reperfusion
Ferreira, A. J., Santos, R. A. S., & Almeida, A. P. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.665 · Cited by 240
Renal ACE2 expression in human kidney disease
Lely, A., Hamming, I., van Goor, H., & Navis, G. (2004) · The Journal of Pathology · doi:10.1002/path.1670 · Cited by 239
Luque, M., Martin, P., Martell, N., Fernandez, C., Brosnihan, K. B., & Ferrario, C. M. (1996) · Journal of Hypertension · doi:10.1097/00004872-199606000-00017 · Cited by 230
Self-citationVascular gp91 phox : Beyond the Endothelium
Pagano, P. J. (2000) · Circulation Research · doi:10.1161/01.res.87.1.1 · Cited by 229
Iyer, S. N., Ferrario, C. M., & Chappell, M. C. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.356 · Cited by 228
Self-citationIyer, S. N., Chappell, M. C., Averill, D. B., Diz, D. I., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.699 · Cited by 227
Self-citationAngiotensin-(1-7) in Normal and Preeclamptic Pregnancy
Merrill, D. C., Karoly, M., Chen, K., Ferrario, C. M., & Brosnihan, K. B. (2002) · Endocrine · doi:10.1385/endo:18:3:239 · Cited by 225
Self-citationAntihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
Benter, I. F., Ferrario, C. M., Morris, M., & Diz, D. I. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.1.h313 · Cited by 225
Self-citationDonoghue, M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00177-9 · Cited by 214
Igase, M., Strawn, W. B., Gallagher, P. E., Geary, R. L., & Ferrario, C. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2005 · Cited by 203
Self-citationConverting Enzyme Determines Plasma Clearance of Angiotensin-(1–7)
Yamada, K., Iyer, S. N., Chappell, M. C., Ganten, D., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.496 · Cited by 203
Self-citationCardiovascular actions of angiotensin(1–7)
Benter, I. F., Diz, D. I., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90097-z · Cited by 201
Self-citationYamamoto, K., Chappell, M. C., Brosnihan, K. B., & Ferrario, C. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.692 · Cited by 189
Self-citationSantos, R. A. S., Ferreira, A. J., Nadu, A. P., Braga, A. N. G., de Almeida, A. P., Campagnole-Santos, M. J., Baltatu, O., Iliescu, R., Reudelhuber, T. L., & Bader, M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00227.2003 · Cited by 187
Converting enzyme activity and angiotensin metabolism in the dog brainstem.
Santos, R. A., Brosnihan, K. B., Chappell, M. C., Pesquero, J., Chernicky, C. L., Greene, L. J., & Ferrario, C. M. (1988) · Hypertension · doi:10.1161/01.hyp.11.2_pt_2.i153 · Cited by 186
Self-citationLosartan Increases Bradykinin Levels in Hypertensive Humans
Campbell, D. J., Krum, H., & Esler, M. D. (2005) · Circulation · doi:10.1161/01.cir.0000153269.07762.3b · Cited by 184
Angiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Strawn, W. B., Ferrario, C. M., & Tallant, E. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.207 · Cited by 184
Self-citationAngiotensin-(1-7): a new hormone of the angiotensin system.
Ferrario, C. M., Brosnihan, K. B., Diz, D. I., Jaiswal, N., Khosla, M. C., Milsted, A., & Tallant, E. A. (1991) · Hypertension · doi:10.1161/01.hyp.18.5_suppl.iii126 · Cited by 182
Self-citationKittleson, M. M., Minhas, K. M., Irizarry, R. A., Ye, S. Q., Edness, G., Breton, E., Conte, J. V., Tomaselli, G., Garcia, J. G. N., & Hare, J. M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00255.2004 · Cited by 174
Blendea, M. C., Jacobs, D., Stump, C. S., McFarlane, S. I., Ogrin, C., Bahtyiar, G., Stas, S., Kumar, P., Sha, Q., Ferrario, C. M., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00402.2004 · Cited by 171
Self-citationTurner, A. J., Tipnis, S. R., Guy, J. L., Rice, G. I., & Hooper, N. M. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-021 · Cited by 169
Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Tallant, E. A., & Clark, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000090322.55782.30 · Cited by 167
Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A., & Burns, K. D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00144.2004 · Cited by 155
Bradykinin, angiotensin-(1–7), and ACE inhibitors: how do they interact?
Tom, B., Dendorfer, A., & Danser, A. H. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00273-x · Cited by 136
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
Tallant, E. A., Diz, D. I., & Ferrario, C. M. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.950 · Cited by 133
Self-citationCardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy
Averill, D. B., Ishiyama, Y., Chappell, M. C., & Ferrario, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000092888.63239.54 · Cited by 132
Self-citationAntithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)
Kucharewicz, I., Pawlak, R., Matys, T., Pawlak, D., & Buczko, W. (2002) · Hypertension · doi:10.1161/01.hyp.0000035396.27909.40 · Cited by 131
Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy
Brosnihan, K. B., Neves, L. A. A., Joyner, J., Averill, D. B., Chappell, M. C., Sarao, R., Penninger, J. M., & Ferrario, C. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000085220.53285.11 · Cited by 128
Self-citationEnhanced expression of Ang-(1-7) during pregnancy
Brosnihan, K. B., Neves, L. A. A., Anton, L., Joyner, J., Valdés, G., & Merrill, D. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000800017 · Cited by 126
Pathways for angiotensin-(1—7) metabolism in pulmonary and renal tissues
Allred, A. J., Diz, D. I., Ferrario, C. M., & Chappell, M. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.5.f841 · Cited by 124
Self-citationThe Adipose Tissue as a Source of Vasoactive Factors
Frühbeck, G. (2004) · Current Medicinal Chemistry - Cardiovascular & Hematological Agents · doi:10.2174/1568016043356255 · Cited by 123
Yagil, Y., & Yagil, C. (2003) · Hypertension · doi:10.1161/01.hyp.0000063886.71596.c8 · Cited by 114
Differential actions of renal ischemic injury on the intrarenal angiotensin system
Allred, A. J., Chappell, M. C., Ferrario, C. M., & Diz, D. I. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f636 · Cited by 113
Self-citationExploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries
Turner, A. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310723 · Cited by 110
Angiotensin-(1-7) and Nitric Oxide Interaction in Renovascular Hypertension
Nakamoto, H., Ferrario, C. M., Fuller, S. B., Robaczewski, D. L., Winicov, E., & Dean, R. H. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.796 · Cited by 109
Self-citationChappell, M. C., Modrall, J. G., Diz, D. I., & Ferrario, C. M. (2004) · KARGER eBooks · doi:10.1159/000078713 · Cited by 105
Self-citationAngiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells
Clark, M. A., Diz, D. I., & Tallant, E. A. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1141 · Cited by 96
Benjafield, A., Wang, W. Y. S., & Morris, B. J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.022 · Cited by 94
Identification of angiotensin converting enzyme 2 in the rodent retina
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Thomas, M. C., Lew, R. A., Yarski, M. A., Smith, A. I., & Cooper, M. E. (2004) · Current Eye Research · doi:10.1080/02713680490517944 · Cited by 93
Moriguchi, A., Tallant, E. A., Matsumura, K., Reilly, T. M., Walton, H. L., Ganten, D., & Ferrario, C. M. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1260 · Cited by 90
Self-citationAngiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts
Ferreira, A. J., Santos, R. A. S., & Almeida, A. P. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000900009 · Cited by 84
The renin–angiotensin system: peptides and enzymes beyond angiotensin II
Reudelhuber, T. L. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200503000-00011 · Cited by 81
Komatsu, T., Suzuki, Y., Imai, J., Sugano, S., Hida, M., Tanigami, A., Muroi, S., Yamada, Y., & Hanaoka, K. (2002) · DNA sequence · doi:10.1080/1042517021000021608 · Cited by 80
Iyer, S. N., Yamada, K., Diz, D. I., Ferrario, C. M., & Chappell, M. C. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200007000-00015 · Cited by 79
Self-citationBenter, I. F., Diz, D. I., & Ferrario, C. M. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.1138 · Cited by 79
Self-citationAngiotensin-(1–7): A Novel Peptide in the Ovary
Costa, A. P. R., Fagundes-Moura, C. R., Pereira, V. M., Silva, L. F., Vieira, M. A. R., Santos, R. A. S., & dos Reis, A. M. (2003) · Endocrinology · doi:10.1210/en.2002-220787 · Cited by 77
Jaiswal, N., Tallant, E. A., Jaiswal, R. K., Diz, D. I., & Ferrario, C. M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38196-6 · Cited by 74
Self-citationValdés, G., Germaín, A., Corthorn, J., Berríos, C., Foradori, A., Ferrario, C. M., & Brosnihan, K. B. (2001) · Endocrine · doi:10.1385/endo:16:2:117 · Cited by 73
Self-citationEffects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension
Ferrario, C. M., Smith, R. D., Brosnihan, B., Chappell, M. C., Campese, V. M., Vesterqvist, O., Liao, W., Ruddy, M. C., & Grim, C. E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02268-9 · Cited by 73
Self-citationAngiotensin(1–7) potentiates bradykinin-induced vasodilatation in man
Ueda, S., Masumori‐Maemoto, S., Wada, A., Ishii, M., Brosnihan, K. B., & Umemura, S. (2001) · Journal of Hypertension · doi:10.1097/00004872-200111000-00010 · Cited by 73
Ac-SDKP Reverses Cardiac Fibrosis in Rats With Renovascular Hypertension
Peng, H., Carretero, O. A., Brigstock, D. R., Oja-Tebbe, N., & Rhaleb, N. (2003) · Hypertension · doi:10.1161/01.hyp.0000100423.24330.96 · Cited by 70
Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones
Ambühl, P., Felix, D., Imboden, H., et al. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90049-z · Cited by 68
Silva, A. C. S. E., Diniz, J. S. S., Filho, A. R., & Santos, R. A. S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.03.055 · Cited by 68
Crossover design to test antihypertensive drugs with self-recorded blood pressure.
Ménard, J., Serrurier, D., Bautier, P., Plouin, P., & Corvol, P. L. (1988) · Hypertension · doi:10.1161/01.hyp.11.2.153 · Cited by 68
Mello, W. C. D. (2004) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2004.041 · Cited by 63
The renin-angiotensin system during acute myocardial ischemia in dogs.
Santos, R. A. S., Brum, J. M., Brosnihan, K. B., & Ferrario, C. M. (1990) · Hypertension · doi:10.1161/01.hyp.15.2_suppl.i121 · Cited by 62
Self-citationACE and ACE2: a tale of two enzymes
Zisman, L. S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi043 · Cited by 60
Kocks, M. J. A., Lely, A. T., Boomsma, F., de Jong, P. E., & Navis, G. J. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160217.86597.b6 · Cited by 46
Angiotensin-(1–7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat
Krob, H. A., Vinsant, S. L., Ferrario, C. M., & Friedman, D. P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00384-9 · Cited by 45
Self-citationEffects of truncated angiotensins in humans after double blockade of the renin system
Plovsing, R. R., Wamberg, C., Sandgaard, N. C. F., Simonsen, J. A., Holstein‐Rathlou, N., Høilund‐Carlsen, P. F., & Bie, P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00263.2003 · Cited by 38
Downregulation of the AT1A Receptor by Pharmacologic Concentrations of Angiotensin-(1-7)
Clark, M. A., Tallant, E. A., & Diz, D. I. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200104000-00011 · Cited by 37
Characterization of angiotensin-(1–7) receptor subtype in mesenteric arteries
Neves, L. A. A., Averill, D. B., Chappell, M. C., et al. (2003) · Peptides · doi:10.1016/s0196-9781(03)00062-7 · Cited by 35
The antithrombotic effect of angiotensin-(1—7) closely resembles that of losartan
Kucharewicz, I., Chabielska, E., Pawlak, D., Matys, T., Rółkowski, R., & Buczko, W. (2000) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2000.041 · Cited by 30
Is angiotensin II made inside or outside of the cell?
Chai, W., & Danser, A. H. J. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0086-0 · Cited by 30
Schiavone, M. T., Khosla, M. C., & Ferrario, C. M. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199016004-00006 · Cited by 26
Self-citationFreeman, E. J., Ferrario, C. M., & Tallant, E. A. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00221-a · Cited by 21
Self-citationAngiotensin-(1–7) stimulates oxidative stress in rat kidney
Gonzales, S., Noriega, G. O., Tomaro, M. L., & Peña, C. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00032-0 · Cited by 18
Jalil, J., Ocaranza, M. P., Oliveri, C., Samuel Córdova, A., Godoy, I. E., Chamorro, G., Braun, S. L., Fardella, C., Jb, M., & Lavandero, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001646 · Cited by 17
Cited by
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G., Voors, A. A., Osterhaus, A. D., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,081
Tikellis, C., & Thomas, M. C. (2012) · International Journal of Peptides · doi:10.1155/2012/256294 · Cited by 624
Classical Renin‐Angiotensin System in Kidney Physiology
Sparks, M. A., Crowley, S. D., Gurley, S. B., Mirotsou, M., & Coffman, T. M. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130040 · Cited by 521
Ferrario, C. M., & Strawn, W. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.059 · Cited by 512
Self-citationThe emerging role of ACE2 in physiology and disease
Hamming, I., Cooper, M., Haagmans, B., Hooper, N., Korstanje, R., Osterhaus, A., Timens, W., Turner, A., Navis, G., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2162 · Cited by 434
Metadata
- Authors
- Ferrario, C. M., Trask, A. J., & Jessup, J. A.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2005-12
- Volume
- 289
- Issue
- 6
- Pages
- H2281-H2290
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2119642994
- Cited by
- 385
- References
- 102
- FWCI
- 15.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.